EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Calcium-Deficient hydroxyapatite as a bone graft material: From hydrated-layer chemistry to clinical performance

Marc Bohner, Nicola Döbelin, Christophe Drouet, Maria-Pau Ginebra, Yassine Maazouz, David Marchat

Acta Biomaterialia · 2026-07 · 218 · 1-37

DOI: 10.1016/j.actbio.2026.06.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2026-07. Verfasst von Marc Bohner und 5 weiteren Autor:innen. Beteiligte Einrichtung: RMS Foundation, Robert Mathys Strasse 1, CH-2544 Bettlach, Switzerland. Electronic address: marc.bohner@rms-foundation.ch. Hauptthemen laut MEDLINE: Bone Substitutes, Durapatite, Calcium, Bone Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 411 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calcium-deficient hydroxyapatite (CDHA) is a widely studied calcium phosphate biomaterial due to its chemical similarity to bone mineral and its relevance as a bone graft substitute. This review presents a comprehensive analysis of CDHA's structure, composition, physico-chemical properties, synthesis methods, and biological performance. Attention is given to the material's multiphasic nature, consisting of a crystalline core and an amorphous hydrated surface layer, and to how this structural-chemical duality governs CDHA's thermal stability, mechanical behavior, solubility, and ion exchange capacity. Various synthesis routes, including aqueous precipitation, hydrolysis, and cementitious reactions, are examined with respect to their impact on particle morphology and clinical applicability. Biological performance is assessed through in vitro and in vivo studies, highlighting CDHA's biocompatibility, osteoconductivity, osteoinductivity, and resorption mechanisms. Challenges such as precise compositional characterization and the dynamic behavior of the hydrated surface layer are addressed, underscoring the need for further research. Overall, CDHA stands out as a promising and versatile material for bone substitution, with significant potential for future developments in regenerative medicine and beyond. STATEMENT OF SIGNIFICANCE: Calcium-deficient hydroxyapatite (CDHA) is widely used as a bone graft substitute, yet its structure, composition, and biological behavior are often misunderstood or inconsistently described. This review provides a focused and chemically rigorous analysis of CDHA as a distinct material class within the Ca-P-O-H system, separating it from ion-substituted or loosely defined "biomimetic" apatites. By critically examining its crystalline core, hydrated surface layer, synthesis pathways, ion-exchange properties, and in vivo performance, we try to clarify long-standing ambiguities regarding its solubility, resorption, and osteoinductive potential. The review highlights the central role of the hydrated layer in governing reactivity and biological response, offering guidance for improved characterization, terminology harmonization, and rational design of next-generation bone graft substitutes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone SubstitutesDurapatiteCalciumBone TransplantationHumansAnimals

Stichwörter der Autor:innen

Biomimetic apatiteBoneCalcium phosphateCalcium-deficient hydroxyapatiteHydrated layerOsteoconductionOsteoinduction

Substanzen

Bone SubstitutesDurapatiteCalcium

Autor:innen und Institutionen

  • RMS Foundation, Robert Mathys Strasse 1, CH-2544 Bettlach, Switzerland. Electronic address: marc.bohner@rms-foundation.ch.
  • RMS Foundation, Robert Mathys Strasse 1, CH-2544 Bettlach, Switzerland.
  • Université de Toulouse, Toulouse INP, CNRS, CIRIMAT, Toulouse, France.
  • Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering and Barcelona Research Center in Multiscale Science and Engineering, Universitat Politècnica de Catalunya - Barcel…
  • Mines Saint-Étienne, Université Jean Monnet, INSERM U1059 Sainbiose, Saint-Étienne, France.

Zitieren

APA

Bohner, M., Döbelin, N., Drouet, C., Ginebra, M. P., Maazouz, Y., & Marchat, D. (2026). Calcium-Deficient hydroxyapatite as a bone graft material: From hydrated-layer chemistry to clinical performance. Acta Biomaterialia, 218, 1-37. https://doi.org/10.1016/j.actbio.2026.06.010

Vancouver

Bohner M, Döbelin N, Drouet C, Ginebra MP, Maazouz Y, Marchat D. Calcium-Deficient hydroxyapatite as a bone graft material: From hydrated-layer chemistry to clinical performance. Acta Biomaterialia. 2026;218:1-37. doi:10.1016/j.actbio.2026.06.010

BibTeX
@article{Bohner2026,
  author = {Bohner, Marc and Döbelin, Nicola and Drouet, Christophe and Ginebra, Maria-Pau and Maazouz, Yassine and Marchat, David},
  title = {Calcium-Deficient hydroxyapatite as a bone graft material: From hydrated-layer chemistry to clinical performance},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {218},
  pages = {1--37},
  doi = {10.1016/j.actbio.2026.06.010}
}
Kostenlos starten →